This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

Flexibility of dosing

DELSTRIGO® Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]
PIFELTRO® Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

Doravirine/3TC/TDF = DELSTRIGO (doravirine/lamivudine/tenofovir disoproxil fumarate)

In patients with HIV-1, doravirine provides

Flexible and convenient dosing1,2

In patients with HIV-1, doravirine provides Flexible and convenient dosing(1,2)
DELSTRIGO®▼ (Doravirine/lamivudine/tenofovir disoproxil fumarate) Complete regimen. Please refer to supporting documentation.
PIFELTRO®▼ (Doravirine) 100 mg (NNRTI). Single agent to be used as part of a regimen with other Antiretrovirals (ARVs).

Can be taken once daily, any time of day

Free of food restrictions

Doravirine does not contain a booster

ARV = Antiretroviral; NNRTI = Non-nucleoside Reverse Transcriptase Inhibitor; NRTI = Nucleoside Reverse Transcriptase Inhibitor.

View other MSD HIV products...

References

  1. DELSTRIGO Summary of Product Characteristics.
  2. PIFELTRO Summary of Product Characteristics.

Supporting documentation

DELSTRIGO® Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland)
PIFELTRO® Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland)
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website

GB-DOR-00084 | Date of Preparation: June 2020